[Treatment of Australia antigen positive hepatitis with 2-mercaptopropionylglycine (Thiola)].
D005455:Fluorescent Antibody Technique; D005998:Glycine / Q000008:administration & dosage / Q000627:therapeutic use*; D006509:Hepatitis B / Q000188:drug therapy* / Q000276:immunology; D006511:Hepatitis B Antigens; D006801:Humans; D013438:Sulfhydryl Compounds / Q000008:administration & dosage / Q000627:therapeutic use*
D006511:Hepatitis B Antigens; D013438:Sulfhydryl Compounds; D005998:Glycine